CIK: 0001674712 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 13, 2025
Total Value ($000): $892,617 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SLNO | Soleno Therapeutics Inc | 6,291,851 | $282,819 | 31.7% | $19.93 | +160.0% | Common | 834203309 |
| — | Verona Pharma PLC | 2,283,975 | $106,068 | 11.9% | $6.97 | — | SPONSORED ADS | 925050106 |
| GERN | Geron Corp | 27,225,292 | $96,378 | 10.8% | $1.62 | +147.1% | Common | 374163103 |
| TERN | Terns Pharmaceuticals Inc | 6,895,746 | $38,202 | 4.3% | $11.04 | -38.7% | Common | 880881107 |
| — | Avadel Pharmaceuticals PLC | 2,684,109 | $28,210 | 3.2% | $13.12 | — | ADR | G29687103 |
| DYN | Dyne Therapeutics Inc | 1,114,960 | $26,268 | 2.9% | $18.65 | +58.6% | Common | 26818M108 |
| ACRS | Aclaris Therapeutics, Inc. | 8,888,888 | $22,044 | 2.5% | $2.49 | 0.0% | Common | 00461U105 |
| DCTH | Delcath Systems, Inc. | 1,708,579 | $20,571 | 2.3% | $7.32 | +44.1% | Common | 24661P807 |
| VRDN | Viridian Therapeutics Inc | 982,576 | $18,836 | 2.1% | $15.47 | +40.6% | Common | 92790C104 |
| — | Cidara Therapeutics, Inc. | 670,600 | $18,026 | 2.0% | $26.88 | — | Common | 171757206 |
| ERAS | Erasca Inc | 6,756,756 | $16,959 | 1.9% | $2.16 | +27.1% | Common | 29479A108 |
| TRVI | Trevi Therapeutics Inc | 3,487,903 | $14,370 | 1.6% | $3.10 | +3.4% | Common | 89532M101 |
| — | Astria Therapeutics Inc | 1,552,685 | $13,881 | 1.6% | $6.12 | — | Common | 04635X102 |
| RZLT | Rezolute Inc | 2,797,704 | $13,709 | 1.5% | $1.28 | +294.7% | Common | 76200L309 |
| SERA | Sera Prognostics Inc | 1,650,440 | $13,435 | 1.5% | $10.38 | -29.2% | Common | 81749D107 |
| — | Tourmaline Bio Inc. | 591,882 | $12,003 | 1.3% | $26.18 | — | Common | 89157D105 |
| CRVS | Corvus Pharmaceuticals Holdings | 2,234,566 | $11,955 | 1.3% | $4.87 | +53.3% | Common | 221015100 |
| TIL | Instil Bio Inc | 585,485 | $11,177 | 1.3% | $7.23 | +321.5% | Common | 45783C200 |
| ORIC | Oric Pharmaceuticals Inc | 1,277,818 | $10,312 | 1.2% | $8.39 | +9.4% | Common | 68622P109 |
| ABEO | Abeona Therapeutics, Inc. | 1,842,751 | $10,264 | 1.1% | $5.10 | +20.6% | Common | 00289Y206 |
| ZBIO | Zenas Biopharma Inc | 1,183,260 | $9,691 | 1.1% | $17.98 | -13.2% | Common | 98937L105 |
| DRUG | Bright Minds Biosciences Inc | 251,572 | $9,062 | 1.0% | $35.19 | 0.0% | Common | 10919W405 |
| OLMA | Olema Pharmaceuticals Inc | 1,505,862 | $8,779 | 1.0% | $31.43 | -68.2% | Common | 68062P106 |
| COGT | Cogent Biosciences Inc | 1,122,471 | $8,755 | 1.0% | $8.55 | +16.6% | Common | 19240Q201 |
| CELC | Celcuity Inc | 610,500 | $7,991 | 0.9% | $16.73 | -15.7% | Common | 15102K100 |
| VSTM | Verastem Inc | 1,538,461 | $7,954 | 0.9% | $6.94 | -43.3% | Common | 92337C203 |
| — | Unicycive Therapeutics | 9,970,152 | $7,918 | 0.9% | $0.78 | — | Common | 90466Y103 |
| — | Regulus Therapeutics Inc | 5,000,000 | $7,900 | 0.9% | $2.88 | — | Common | 75915K309 |
| SLN | Silence Therapeutics PLC | 1,105,454 | $7,606 | 0.9% | $19.65 | — | ADS | 82686Q101 |
| CMPS | Compass Pathway PLC | 1,608,000 | $6,078 | 0.7% | $7.40 | — | SPONSORED ADS | 20451W101 |
| IOBT | IO Biotech Inc | 6,173,439 | $5,680 | 0.6% | $5.62 | -82.3% | Common | 449778109 |
| ALGS | Aligos Therapeutics Inc | 141,879 | $5,652 | 0.6% | $12.44 | +55.4% | Common | 01626L204 |
| CMPX | Compass Therapeutics Inc | 3,556,023 | $5,156 | 0.6% | $3.60 | -53.8% | Common | 20454B104 |
| — | Allakos Inc | 2,956,110 | $3,577 | 0.4% | $6.12 | — | Common | 01671P100 |
| CRBP | Corbus Pharmaceuticals Holdings | 166,794 | $1,968 | 0.2% | $42.06 | -60.1% | Common | 21833P301 |
| — | Bolt Therapeutics Inc | 3,521,291 | $1,884 | 0.2% | $32.91 | — | Common | 097702104 |
| TENX | Tenax Therapeutics Inc | 208,333 | $1,290 | 0.1% | $3.62 | +34.0% | Common | 88032L605 |
| DBVT | DBV Technologies SA | 32,020 | $99 | 0.0% | $3.09 | — | SPONSORED ADS | 23306J309 |
| QTTB | Q32 Bio Inc. | 20,559 | $71 | 0.0% | $13.78 | +129.2% | Common | 746964105 |
| DTIL | Precision Biosciences Inc | 4,675 | $18 | 0.0% | $12.24 | -40.3% | Common | 74019P207 |